SCHEMBL20103349

SCHEMBL20103349

COc1ccc(F)c(C2CCC(COc3cccc(CCC#N)c3)CC2)c1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 14/20 0.55
TAAR1 Q96RJ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20103495 0.83 FFAR1 (0.61) FFAR1
SCHEMBL20103237 0.83 FFAR1 (0.66) FFAR1
SCHEMBL20103624 0.83 FFAR1 (0.60) FFAR1
SCHEMBL21644860 0.79 FFAR1 (0.73) FFAR1
SCHEMBL20103486 0.79 FFAR1 (0.73) FFAR1
SCHEMBL20103348 0.79 FFAR1 (0.73) FFAR1
SCHEMBL21688414 0.79 FFAR1 (0.73) FFAR1
SCHEMBL21688387 0.79 FFAR1 (0.73) FFAR1
SCHEMBL21644863 0.79 FFAR1 (0.73) FFAR1
SCHEMBL20103338 0.78 FFAR1 (0.68) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081047-A1 CYCLOHEXYL GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed